Related references
Note: Only part of the references are listed.Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer
Rulla M. Tamimi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
S. Park et al.
ANNALS OF ONCOLOGY (2011)
Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor-Positive and -Negative Breast Cancer: a Nested Case-Control Study
Rebecca E. James et al.
CANCER PREVENTION RESEARCH (2011)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers
Ghada N. Farhat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Physical Activity and Risk of Breast Cancer Among Postmenopausal Women
A. Heather Eliassen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
Isabella Castellano et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women
Laura Baglietto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET Cohort
Sabina Sieri et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Androgens and the breast
Constantine Dimitrakakis et al.
BREAST CANCER RESEARCH (2009)
Determination of blood pressure percentiles in normal-weight children: Some methodological issues
B. Rosner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study
Bernard Rosner et al.
BREAST CANCER RESEARCH (2008)
Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk
Susan E. Hankinson et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
Elizabeth Barrett-Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanisms of disease: Estrogen carcinogenesis in breast cancer
JD Yager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Postmenopausal serum androgens, oestrogens and breast cancer risk:: the European prospective investigation into cancer and nutrition
R Kaaks et al.
ENDOCRINE-RELATED CANCER (2005)
Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: A long-term prospective study
SR Cummings et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
The Nurses' Health Study: Lifestyle and health among women
GA Colditz et al.
NATURE REVIEWS CANCER (2005)
Risk factors for breast cancer according to estrogen and progesterone receptor status
GA Colditz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Plasma prolactin concentrations and risk of postmenopausal breast cancer
SS Tworoger et al.
CANCER RESEARCH (2004)
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women
SA Missmer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Prognostic significance of intra-tumoral estradiol level in breast cancer patients
Y Miyoshi et al.
CANCER LETTERS (2004)
Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
A Zeleniuch-Jacquotte et al.
BRITISH JOURNAL OF CANCER (2004)
Roles of androgens in the development, growth, and carcinogenesis of the mammary gland
DJ Liao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial
M Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
